Anatara Lifesciences Limited
-
Ticker
ANR
-
Industry
Biotechnology More
-
Sector
Healthcare More
- 1-10 Employees
- Based in Carlton, Australia
Anatara Lifesciences Limited engages in the research and development of evidence based solutions for gastrointestinal diseases in animals and humans in Australia. It offers Gastrointestinal ReProgramming (GaRP), a proprietary formulation that combines bromelain with other evidence-based ingredients to address the primary underlying factors associated with human gastrointestinal conditions
…More, such as irritable bowel syndrome (IBS) and inflammatory bowel disease (IBD); and 3FDC for the treatment of anxiety, stress, or depression. The company also provides Detach for the treatment of diarrhea disease in piglets. In addition, it is developing bromelain-based formulations for piglets and poultry. Anatara Lifesciences Limited was incorporated in 2010 and is based in Carlton, Australia.
REPORT RATINGS
4.8 / 5.0 (86)
Anatara Lifesciences Limited reports have an aggregate usefulness score of 4.8 based on 86 reviews.
Anatara Lifesciences Limited
Most Recent Annual Report
MOST RECENT
2023 Annual Report
Older/Archived Annual Reports